Epic’s lawsuit against Health Gorilla is less about one alleged data misuse scheme and more about a deeper fault line in healthcare interoperability: data can move faster than the rules governing it. Experts say this problem could force the industry to redefine the boundaries of access, accountability and trust in data sharing. The post Epic…
People like Oprah Winfrey have struggled to maintain their weight loss after weaning themselves off GLP-1s. What if an outpatient medtech procedure did the trick? The post What if Oprah Knew About Fractyl Health? appeared first on MedCity News.
The Host Julie Rovner KFF Health News @jrovner @julierovner.bsky.social Read Julie’s stories. Julie Rovner is chief Washington correspondent and host of KFF Health News’ weekly health policy news podcast, “What the Health?” A noted expert on health policy issues, Julie is the author of the critically praised reference book “Health Care Politics and Policy A…
This policy watch discusses the implications for the U.S. health care workforce of the recent DOS immigrant visa pause for individuals from 75 countries deemed more likely to be a public charge.
Health-ISAC’s 2026 report warns of evolving threats like AI-driven attacks, sophisticated social engineering, and legacy device vulnerabilities
Tenpoint Therapeutics’ Yuvezzi brings a combination approach to presbyopia compared to single mechanisms of action offered by once-daily eye drops from Orasis Pharmaceuticals, Lenz Therapeutics, and AbbVie. Yuvezzi’s commercialization will be supported by up to $235 million in financing. The post Presbyopia Eye Drop From Startup Tenpoint Gets FDA Approval, Paving Way for $235M Financing…
In support of the WFTC legislation, CMS partners with tech firms to facilitate Medicaid community engagement
Silna Health’s solution evaluates whether clinical documentation meets payer requirements before a prior authorization is submitted
Personalized and highly-targeted therapeutics are becoming more common, making local or regional production increasingly valuable for faster patient access. This underscores how a hybrid network combining large, centralized plants coupled with flexible regional sites will define the next era of resilient biomanufacturing. The post Moving Beyond the Mega-Factory: Why the Future of Biomanufacturing is Agile,…
Effective specimen collection during the pivotal collection period guides everything that follows, from individual therapeutic decisions to large-scale community outbreak control. The post The 96-Hour Advantage: Why Early Diagnostic Accuracy Defines Clinical Outcomes appeared first on MedCity News.